Industry news that matters to you.  Learn more

Cleveland BioLabs Announces Publication of Studies Identifying Biomarkers of CBLB502’s Efficacy as a Radiation Countermeasure

Cleveland BioLabs, Inc. (Nasdaq:CBLI) recently announced the online publication of studies identifying biomarkers of CBLB502’s efficacy as a radiation countermeasure in the Journal of Pharmacology and Experimental Therapeutics, a leading peer-reviewed research journal in the field of pharmacology. The reported studies were conducted by scientists of Cleveland BioLabs in collaboration with researchers at the Armed Forces Radiobiology Research Institute and the F. Edward Hébert School of Medicine at the Uniformed Services University of the Health Sciences, and Roswell Park Cancer Institute.

Biomarker Test for Rheumatoid Arthritis Proves Effective in Study

A simple blood test may help physicians track the progression of rheumatoid arthritis disease activity, say researchers at the University of Alabama at Birmingham. In a paper published online on June 26, 2012, in Arthritis Care and Research, the UAB-led international research team says that a blood test measuring 12 biomarkers for RA is a valid and potentially useful tool in managing the disease.

RayBiotech, Inc. and the University of Oslo Enter into Antibody Array Services Collaboration

RayBiotech, Inc. and the combined genotyping core facility for Oslo University Hospital and the University of Oslo, located at the Institute for Cancer Research, announced the execution of an agreement to collaborate for the implementation of antibody-based sample analysis services. Under the terms of the agreement, the combined core facility will provide a comprehensive service utilizing RayBiotech’s proprietary antibody arrays for the high-throughput detection and analysis of protein biomarkers in biological samples. The service program will target academic and industrial research clients having a need for fully quantifiable biomarker analysis.

New Salimetrics Salivary IL-1 Beta Immunoassay Kit

Salimetrics has completed development of an immunoassay kit that is fully validated for the measurement of interleukin-1 beta (IL-1 beta) in saliva samples.

The Bill & Melinda Gates Foundation to Fund Biomarkers of Gut Function for Global Health

The Bill & Melinda Gates Foundation is currently seeking letters of inquiry for the grant program Biomarkers of Gastrointestinal (Gut) Function and Health. Letters of intent are due by January 11th, 2012 at 10:00 a.m. PST. The grant program is part of a new biomarker grand challenge under the Grand Challenges in Global Health, a suite of grant programs intended to help overcome bottlenecks that prevent the creation of new and better health solutions for the developing world.